[go: up one dir, main page]

GB1544761A - Prolonged release pharmaceutical preparations - Google Patents

Prolonged release pharmaceutical preparations

Info

Publication number
GB1544761A
GB1544761A GB48997/77A GB4899777A GB1544761A GB 1544761 A GB1544761 A GB 1544761A GB 48997/77 A GB48997/77 A GB 48997/77A GB 4899777 A GB4899777 A GB 4899777A GB 1544761 A GB1544761 A GB 1544761A
Authority
GB
United Kingdom
Prior art keywords
active compound
pharmaceutical preparations
release pharmaceutical
complex
preparation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB48997/77A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pennwalt Corp
Original Assignee
Pennwalt Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pennwalt Corp filed Critical Pennwalt Corp
Publication of GB1544761A publication Critical patent/GB1544761A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
GB48997/77A 1976-11-26 1977-11-24 Prolonged release pharmaceutical preparations Expired GB1544761A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US74532576A 1976-11-26 1976-11-26
US80010577A 1977-05-24 1977-05-24

Publications (1)

Publication Number Publication Date
GB1544761A true GB1544761A (en) 1979-04-25

Family

ID=27114439

Family Applications (1)

Application Number Title Priority Date Filing Date
GB48997/77A Expired GB1544761A (en) 1976-11-26 1977-11-24 Prolonged release pharmaceutical preparations

Country Status (21)

Country Link
JP (1) JPS609697B2 (es)
AR (1) AR218047A1 (es)
AT (1) AT359197B (es)
AU (1) AU511080B2 (es)
BE (1) BE861141A (es)
CA (1) CA1086226A (es)
CH (1) CH639560A5 (es)
DE (1) DE2752728C2 (es)
DK (1) DK150534C (es)
FI (1) FI65910C (es)
FR (1) FR2373288A1 (es)
GB (1) GB1544761A (es)
GR (1) GR61724B (es)
IE (1) IE45998B1 (es)
IL (1) IL53462A (es)
LU (1) LU78584A1 (es)
NL (1) NL182283C (es)
NO (1) NO147626C (es)
NZ (1) NZ185772A (es)
PT (1) PT67323B (es)
SE (1) SE426781B (es)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0620002A1 (en) * 1993-04-16 1994-10-19 Bristol-Myers Squibb Company A solid pharmaceutical dosage form and a method for reducing abrasion
FR3059903A1 (fr) * 2016-12-08 2018-06-15 Salsarulo Pharma Medicament oral comprenant un laxatif osmotique incorpore dans une matrice a base de matieres grasses vegetales
JP2022534225A (ja) * 2019-05-23 2022-07-28 ジー．デー ソチエタ ペル アツィオニ 容器、特にカートリッジに、製薬産業の液体製品を充填するための充填ユニット

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2929456A1 (de) 1979-07-20 1981-02-05 Lentia Gmbh Zusammensetzung mit verlaengerter broncholytischer und tokolytischer wirksamkeit, ein verfahren zu deren herstellung und broncholytisch und tokolytisch wirkendes mittel
CA1236023A (en) * 1984-07-18 1988-05-03 Yegnaswami Raghunathan Controlled release pharmaceutical preparations
US4692462A (en) * 1985-03-18 1987-09-08 Menley & James Laboratories, Ltd. Compositions and method of controlling transdermal penetration of topical and systemic agents
US5612059A (en) * 1988-08-30 1997-03-18 Pfizer Inc. Use of asymmetric membranes in delivery devices
US5188825A (en) * 1989-12-28 1993-02-23 Iles Martin C Freeze-dried dosage forms and methods for preparing the same
CA2087435C (en) * 1990-08-07 1998-05-05 Scott Max Herbig Use of interfacially-polymerized membranes in delivery devices
US20130230587A1 (en) * 2010-11-10 2013-09-05 Rubicon Research Private Limited Sustained release compositions
KR102901919B1 (ko) 2017-10-09 2025-12-17 로도스 파머시티컬스 엘.피. 약학 수지산염 조성물 및 그 제조 및 사용 방법

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE550150A (es) * 1955-08-08
GB843118A (en) * 1957-02-13 1960-08-04 Ici Ltd Pharmaceutical compositions containing piperidine derivatives
US3158538A (en) * 1961-02-23 1964-11-24 White Lab Inc Antidiarrheal compositions and method of using
GB982150A (en) * 1961-09-29 1965-02-03 Glaxo Group Ltd Therapeutic resin complexes
US3594470A (en) * 1968-02-19 1971-07-20 Abbott Lab Chewable tablets including coated particles of pseudoephedrine-weak cation exchange resin
GB1218102A (en) * 1968-03-15 1971-01-06 Philips Nv Improvements in medicaments comprising drug/ion-exchange resin compounds
CA927282A (en) * 1968-09-03 1973-05-29 S. Banker Gilbert Entrapment compositions and processes
CA935092A (en) * 1968-09-03 1973-10-09 S. Banker Gilbert Molecular drug entrapment process and compositions
DE2343218C2 (de) * 1973-08-28 1986-08-07 Hoechst Ag, 6230 Frankfurt Furosemid enthaltende Pellets

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0620002A1 (en) * 1993-04-16 1994-10-19 Bristol-Myers Squibb Company A solid pharmaceutical dosage form and a method for reducing abrasion
US5436011A (en) * 1993-04-16 1995-07-25 Bristol-Myers Squibb Company Solid pharmaceutical dosage form and a method for reducing abrasion
FR3059903A1 (fr) * 2016-12-08 2018-06-15 Salsarulo Pharma Medicament oral comprenant un laxatif osmotique incorpore dans une matrice a base de matieres grasses vegetales
JP2022534225A (ja) * 2019-05-23 2022-07-28 ジー．デー ソチエタ ペル アツィオニ 容器、特にカートリッジに、製薬産業の液体製品を充填するための充填ユニット

Also Published As

Publication number Publication date
NO774051L (no) 1978-05-29
NO147626C (no) 1983-05-25
IE45998B1 (en) 1983-01-26
FR2373288B1 (es) 1980-06-13
FI773568A7 (fi) 1978-05-27
IL53462A (en) 1980-12-31
NL182283B (nl) 1987-09-16
LU78584A1 (es) 1978-04-20
NZ185772A (en) 1978-12-18
DK150534B (da) 1987-03-23
JPS609697B2 (ja) 1985-03-12
GR61724B (en) 1978-12-29
AR218047A1 (es) 1980-05-15
DK523277A (da) 1978-05-27
AT359197B (de) 1980-10-27
PT67323A (en) 1977-12-01
SE426781B (sv) 1983-02-14
FR2373288A1 (fr) 1978-07-07
DE2752728C2 (de) 1985-08-01
FI65910B (fi) 1984-04-30
DK150534C (da) 1987-10-12
SE7713370L (sv) 1978-05-27
ATA848077A (de) 1980-03-15
DE2752728A1 (de) 1978-06-01
NL7712996A (nl) 1978-05-30
FI65910C (fi) 1984-08-10
IE45998L (en) 1978-05-26
PT67323B (en) 1979-04-24
NL182283C (nl) 1988-02-16
BE861141A (fr) 1978-03-16
NO147626B (no) 1983-02-07
CH639560A5 (en) 1983-11-30
IL53462A0 (en) 1978-01-31
AU3098677A (en) 1979-05-31
AU511080B2 (en) 1980-07-24
CA1086226A (en) 1980-09-23
JPS5369822A (en) 1978-06-21

Similar Documents

Publication Publication Date Title
GB1544761A (en) Prolonged release pharmaceutical preparations
ATE47520T1 (de) Darmloesliche ueberzugsmasse fuer pharmazeutische verabreichungsformen.
DE2966257D1 (en) Mono and oligo saccharides methylolated in the alpha position, methods for their preparation and their application
DE3372173D1 (en) Process for coating galenics with a water-dispersed coating composition
ATE46438T1 (de) Enterischer ueberzug fuer pharmazeutische verabreichungsformen.
ES2010745A6 (es) Procedimiento para la obtencion de un sistema terapeutico para la aplicacion combinada transdermal de estrogenos y de gestagenos.
ZA80553B (en) Process for the preparation of tablets with retarded liberation of the active agent,in which tablets the rate of liberation of the active agent is predetermined
DK196189D0 (da) Oralt osmotisk dispenseringssystem indeholdende et farmakologisk aktivt stof
ES2029285T3 (es) Un procedimiento para la preparacion de un nucleo granulado de rapida disgregacion.
NL7904449A (nl) Polymeersamenstelling alsmede werkwijze voor het ver- dikken van een waterhoudend preparaat
IL59063A (en) Polymeric diffusion matrix for release of pharmaceutical dosage
HU175439B (hu) Insekticidnye kompozicii soderzhahhie proizvodnye n-skobka-3-triflorometil-4-galogeno-fenil-skobka zakryta-n-zapjataja vverkh-benzoil-mocheviny i sposob poluchenija aktivnogo agenta
JPS52122639A (en) Toiletry
KR880001302A (ko) 피복 가능한 이온 교환 수지
JPS55155096A (en) Low foamable surface active agent
JPS5767518A (en) Radiosensitizing agent or agent for increasing effect of radiomimetic substance
HU177972B (en) Fungicide composition and process for producing the active agent
JPS5297926A (en) Process for preparing pharmaceutically active compound* its composition and therapeutical method by utilization thereof
JPS5696067A (en) Diffusion coating through limited part
JPS52114023A (en) Application of termite controlling agent
JPS53148518A (en) Stabilized prostaglandin e composition and its preparation
IL70320A0 (en) Antimycotic agents in the form of gel systems with high release of active compounds
JPS57139011A (en) Material for releasing physiologically active substance
JPS56169623A (en) Anti-inflammatory and pain-killing spreading plaster
JPS5226386A (en) Ion exchanger of composite base material

Legal Events

Date Code Title Description
PS Patent sealed [section 19, patents act 1949]
732 Registration of transactions, instruments or events in the register (sect. 32/1977)
704A Declaration that licence is not available as of right for an excepted use (par. 4a/1977)
PE20 Patent expired after termination of 20 years

Effective date: 19971123